Original Article
When to start secukinumab treatment in patients with axial spondyloarthropathy: Before or after anti-TNFα treatment?
¿Cuándo iniciar el tratamiento con secukinumab en pacientes con espondiloartropatía axial: antes o después del tratamiento anti-TNFα?
Tumay Aka,d, Leyla Mustafayevab,d, Yeliz Celikc, Ali Yagiz Aylac, Serdal Ugurluc,
Corresponding author
a Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
b Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Physical Therapy and Rehabilitation, Istanbul, Turkey
c Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
Read
3724
Timeswas read the article
1340
Total PDF
2384
Total HTML
Share statistics
Article information
ISSN: 21735743Original language: English
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2026 1 | 222 | 119 | 341 |
| 2025 12 | 284 | 149 | 433 |
| 2025 11 | 290 | 57 | 347 |
| 2025 10 | 25 | 61 | 86 |
| 2025 9 | 0 | 53 | 53 |
| 2025 8 | 0 | 41 | 41 |
| 2025 7 | 0 | 53 | 53 |
| 2025 6 | 0 | 41 | 41 |
| 2025 5 | 98 | 59 | 157 |
| 2025 4 | 75 | 27 | 102 |
| 2025 3 | 70 | 36 | 106 |
| 2025 2 | 69 | 51 | 120 |
| 2025 1 | 50 | 47 | 97 |
| 2024 12 | 39 | 33 | 72 |
| 2024 11 | 45 | 58 | 103 |
| 2024 10 | 26 | 31 | 57 |
| 2024 9 | 64 | 44 | 108 |
| 2024 8 | 53 | 44 | 97 |
| 2024 7 | 43 | 29 | 72 |
| 2024 6 | 51 | 34 | 85 |
| 2024 5 | 59 | 34 | 93 |
| 2024 4 | 39 | 24 | 63 |
| 2024 3 | 78 | 35 | 113 |
| 2024 2 | 80 | 30 | 110 |
| 2024 1 | 101 | 24 | 125 |
| 2023 12 | 97 | 26 | 123 |
| 2023 11 | 105 | 46 | 151 |
| 2023 10 | 115 | 48 | 163 |
| 2023 9 | 6 | 2 | 8 |
| 2023 5 | 199 | 2 | 201 |
| 2023 4 | 1 | 2 | 3 |
Show all
